Infliximab/methotrexate/tocilizumabLymphoproliferative disorder, anaphylactic shock and rebound effect in the form of rheumatoid arthritis flare: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1946卷 / 1期

关键词：

D O I：

10.1007/s40278-023-34895-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：294 / 294

相关论文

共 23 条

[21] Mycophenolate-mofetil/rituximabGingivitis, low white blood cells and rebound effect in the form of severe high paraplegia: 3 case reports
Reactions Weekly, 2022, 1903 (1) : 293 - 293
[22] Multiple drugsRelapse in bipolar disorder following the off-label use and rebound effect following inadvertent discontinuation of drug: 3 case reports
Reactions Weekly, 2022, 1892 (1) : 166 - 166
[23] Fingolimod/Natalizumab/RituximabThrombocytopenia following in-utero expoure, rebound effect in the form of aggressive multiple sclerosis and drug exposure during pregnancy: 3 case reports
Reactions Weekly, 2024, 2035 (1) : 216 - 216